Why the study?
Are systemic myeloperoxidase levels associated with coronary plaque erosion compared to plaque rupture in patients with acute coronary syndromes?
Population
25 consecutive patients with acute coronary syndromes, mean age 67±11 years, 60% male, plus 22 postmortem…
Comparison
Plaque erosion vs Plaque rupture
Design
Cross-sectional
Authors
Loading...
MPO may aid noninvasive identification of plaque erosion in ACS; hypothesis-generating and requires prospective validation before clinical use.
Are systemic myeloperoxidase levels associated with coronary plaque erosion compared to plaque rupture in patients with acute coronary syndromes?
Systemic myeloperoxidase levels are significantly elevated in ACS patients with eroded culprit plaques compared to those with ruptured plaques, suggesting its potential as a specific biomarker for plaque erosion.
Ferrante et al. (2010) studied this question.